The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Methotrexate Injection Market Research Report 2024
Synopsis
It is used to treat leukemia and certain types of cancer of the breast, skin, head and neck, or lung.
The global Methotrexate Injection market was valued at US$ 155.2 million in 2023 and is anticipated to reach US$ 182.8 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Methotrexate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Methotrexate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Methotrexate Injection include Hikma, Teva, Accord, Fresenius Kabi, Mylan, Pfizer, Get Well Pharmaceutical, Sichuan Huiyu Pharma and Youcare Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Methotrexate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate Injection.
Report Scope
The Methotrexate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methotrexate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methotrexate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hikma
Teva
Accord
Fresenius Kabi
Mylan
Pfizer
Get Well Pharmaceutical
Sichuan Huiyu Pharma
Youcare Pharmaceutical Group
Qilu Pharmaceutical
Shanxi Pude Pharma
Hengrui Medicine
Guangdong Lingnan Pharma
Segment by Type
Preservative-Free
With Preservative
Segment by Application
Hospital
Specialty Clinic
Recovry Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methotrexate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Methotrexate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
It is used to treat leukemia and certain types of cancer of the breast, skin, head and neck, or lung.
The global Methotrexate Injection market was valued at US$ 155.2 million in 2023 and is anticipated to reach US$ 182.8 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Methotrexate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Methotrexate Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Methotrexate Injection include Hikma, Teva, Accord, Fresenius Kabi, Mylan, Pfizer, Get Well Pharmaceutical, Sichuan Huiyu Pharma and Youcare Pharmaceutical Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Methotrexate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methotrexate Injection.
Report Scope
The Methotrexate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Methotrexate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Methotrexate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hikma
Teva
Accord
Fresenius Kabi
Mylan
Pfizer
Get Well Pharmaceutical
Sichuan Huiyu Pharma
Youcare Pharmaceutical Group
Qilu Pharmaceutical
Shanxi Pude Pharma
Hengrui Medicine
Guangdong Lingnan Pharma
Segment by Type
Preservative-Free
With Preservative
Segment by Application
Hospital
Specialty Clinic
Recovry Center
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Methotrexate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Methotrexate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Methotrexate Injection Market Overview
1.1 Product Overview and Scope of Methotrexate Injection
1.2 Methotrexate Injection Segment by Type
1.2.1 Global Methotrexate Injection Market Value Comparison by Type (2024-2030)
1.2.2 Preservative-Free
1.2.3 With Preservative
1.3 Methotrexate Injection Segment by Application
1.3.1 Global Methotrexate Injection Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Recovry Center
1.4 Global Methotrexate Injection Market Size Estimates and Forecasts
1.4.1 Global Methotrexate Injection Revenue 2019-2030
1.4.2 Global Methotrexate Injection Sales 2019-2030
1.4.3 Global Methotrexate Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Methotrexate Injection Market Competition by Manufacturers
2.1 Global Methotrexate Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Methotrexate Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Methotrexate Injection Average Price by Manufacturers (2019-2024)
2.4 Global Methotrexate Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Methotrexate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Methotrexate Injection, Product Type & Application
2.7 Methotrexate Injection Market Competitive Situation and Trends
2.7.1 Methotrexate Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Methotrexate Injection Players Market Share by Revenue
2.7.3 Global Methotrexate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Methotrexate Injection Retrospective Market Scenario by Region
3.1 Global Methotrexate Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Methotrexate Injection Global Methotrexate Injection Sales by Region: 2019-2030
3.2.1 Global Methotrexate Injection Sales by Region: 2019-2024
3.2.2 Global Methotrexate Injection Sales by Region: 2025-2030
3.3 Global Methotrexate Injection Global Methotrexate Injection Revenue by Region: 2019-2030
3.3.1 Global Methotrexate Injection Revenue by Region: 2019-2024
3.3.2 Global Methotrexate Injection Revenue by Region: 2025-2030
3.4 North America Methotrexate Injection Market Facts & Figures by Country
3.4.1 North America Methotrexate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Methotrexate Injection Sales by Country (2019-2030)
3.4.3 North America Methotrexate Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Methotrexate Injection Market Facts & Figures by Country
3.5.1 Europe Methotrexate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Methotrexate Injection Sales by Country (2019-2030)
3.5.3 Europe Methotrexate Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Methotrexate Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Methotrexate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Methotrexate Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Methotrexate Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Methotrexate Injection Market Facts & Figures by Country
3.7.1 Latin America Methotrexate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Methotrexate Injection Sales by Country (2019-2030)
3.7.3 Latin America Methotrexate Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Methotrexate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Methotrexate Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Methotrexate Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Methotrexate Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Methotrexate Injection Sales by Type (2019-2030)
4.1.1 Global Methotrexate Injection Sales by Type (2019-2024)
4.1.2 Global Methotrexate Injection Sales by Type (2025-2030)
4.1.3 Global Methotrexate Injection Sales Market Share by Type (2019-2030)
4.2 Global Methotrexate Injection Revenue by Type (2019-2030)
4.2.1 Global Methotrexate Injection Revenue by Type (2019-2024)
4.2.2 Global Methotrexate Injection Revenue by Type (2025-2030)
4.2.3 Global Methotrexate Injection Revenue Market Share by Type (2019-2030)
4.3 Global Methotrexate Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Methotrexate Injection Sales by Application (2019-2030)
5.1.1 Global Methotrexate Injection Sales by Application (2019-2024)
5.1.2 Global Methotrexate Injection Sales by Application (2025-2030)
5.1.3 Global Methotrexate Injection Sales Market Share by Application (2019-2030)
5.2 Global Methotrexate Injection Revenue by Application (2019-2030)
5.2.1 Global Methotrexate Injection Revenue by Application (2019-2024)
5.2.2 Global Methotrexate Injection Revenue by Application (2025-2030)
5.2.3 Global Methotrexate Injection Revenue Market Share by Application (2019-2030)
5.3 Global Methotrexate Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hikma
6.1.1 Hikma Corporation Information
6.1.2 Hikma Description and Business Overview
6.1.3 Hikma Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hikma Methotrexate Injection Product Portfolio
6.1.5 Hikma Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Methotrexate Injection Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Accord
6.3.1 Accord Corporation Information
6.3.2 Accord Description and Business Overview
6.3.3 Accord Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Accord Methotrexate Injection Product Portfolio
6.3.5 Accord Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Corporation Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Fresenius Kabi Methotrexate Injection Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Methotrexate Injection Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Methotrexate Injection Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Get Well Pharmaceutical
6.6.1 Get Well Pharmaceutical Corporation Information
6.6.2 Get Well Pharmaceutical Description and Business Overview
6.6.3 Get Well Pharmaceutical Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Get Well Pharmaceutical Methotrexate Injection Product Portfolio
6.7.5 Get Well Pharmaceutical Recent Developments/Updates
6.8 Sichuan Huiyu Pharma
6.8.1 Sichuan Huiyu Pharma Corporation Information
6.8.2 Sichuan Huiyu Pharma Description and Business Overview
6.8.3 Sichuan Huiyu Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sichuan Huiyu Pharma Methotrexate Injection Product Portfolio
6.8.5 Sichuan Huiyu Pharma Recent Developments/Updates
6.9 Youcare Pharmaceutical Group
6.9.1 Youcare Pharmaceutical Group Corporation Information
6.9.2 Youcare Pharmaceutical Group Description and Business Overview
6.9.3 Youcare Pharmaceutical Group Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Youcare Pharmaceutical Group Methotrexate Injection Product Portfolio
6.9.5 Youcare Pharmaceutical Group Recent Developments/Updates
6.10 Qilu Pharmaceutical
6.10.1 Qilu Pharmaceutical Corporation Information
6.10.2 Qilu Pharmaceutical Description and Business Overview
6.10.3 Qilu Pharmaceutical Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Qilu Pharmaceutical Methotrexate Injection Product Portfolio
6.10.5 Qilu Pharmaceutical Recent Developments/Updates
6.11 Shanxi Pude Pharma
6.11.1 Shanxi Pude Pharma Corporation Information
6.11.2 Shanxi Pude Pharma Methotrexate Injection Description and Business Overview
6.11.3 Shanxi Pude Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanxi Pude Pharma Methotrexate Injection Product Portfolio
6.11.5 Shanxi Pude Pharma Recent Developments/Updates
6.12 Hengrui Medicine
6.12.1 Hengrui Medicine Corporation Information
6.12.2 Hengrui Medicine Methotrexate Injection Description and Business Overview
6.12.3 Hengrui Medicine Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Hengrui Medicine Methotrexate Injection Product Portfolio
6.12.5 Hengrui Medicine Recent Developments/Updates
6.13 Guangdong Lingnan Pharma
6.13.1 Guangdong Lingnan Pharma Corporation Information
6.13.2 Guangdong Lingnan Pharma Methotrexate Injection Description and Business Overview
6.13.3 Guangdong Lingnan Pharma Methotrexate Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Guangdong Lingnan Pharma Methotrexate Injection Product Portfolio
6.13.5 Guangdong Lingnan Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Methotrexate Injection Industry Chain Analysis
7.2 Methotrexate Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Methotrexate Injection Production Mode & Process
7.4 Methotrexate Injection Sales and Marketing
7.4.1 Methotrexate Injection Sales Channels
7.4.2 Methotrexate Injection Distributors
7.5 Methotrexate Injection Customers
8 Methotrexate Injection Market Dynamics
8.1 Methotrexate Injection Industry Trends
8.2 Methotrexate Injection Market Drivers
8.3 Methotrexate Injection Market Challenges
8.4 Methotrexate Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Methotrexate Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Methotrexate Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Methotrexate Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Methotrexate Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Methotrexate Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Methotrexate Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Methotrexate Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Methotrexate Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Methotrexate Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Methotrexate Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Methotrexate Injection, Product Type & Application
Table 12. Global Key Manufacturers of Methotrexate Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Methotrexate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Methotrexate Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Methotrexate Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Methotrexate Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Methotrexate Injection Sales Market Share by Region (2019-2024)
Table 19. Global Methotrexate Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Methotrexate Injection Sales Market Share by Region (2025-2030)
Table 21. Global Methotrexate Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Methotrexate Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Methotrexate Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Methotrexate Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Methotrexate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Methotrexate Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Methotrexate Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Methotrexate Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Methotrexate Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Methotrexate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Methotrexate Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Methotrexate Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Methotrexate Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Methotrexate Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Methotrexate Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Methotrexate Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Methotrexate Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Methotrexate Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Methotrexate Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Methotrexate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Methotrexate Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Methotrexate Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Methotrexate Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Methotrexate Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Methotrexate Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Methotrexate Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Methotrexate Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Methotrexate Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Methotrexate Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Methotrexate Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Methotrexate Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Methotrexate Injection Sales Market Share by Type (2019-2024)
Table 53. Global Methotrexate Injection Sales Market Share by Type (2025-2030)
Table 54. Global Methotrexate Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Methotrexate Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Methotrexate Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Methotrexate Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Methotrexate Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Methotrexate Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Methotrexate Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Methotrexate Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Methotrexate Injection Sales Market Share by Application (2019-2024)
Table 63. Global Methotrexate Injection Sales Market Share by Application (2025-2030)
Table 64. Global Methotrexate Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Methotrexate Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Methotrexate Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Methotrexate Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Methotrexate Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Methotrexate Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Hikma Corporation Information
Table 71. Hikma Description and Business Overview
Table 72. Hikma Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Hikma Methotrexate Injection Product
Table 74. Hikma Recent Developments/Updates
Table 75. Teva Corporation Information
Table 76. Teva Description and Business Overview
Table 77. Teva Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Methotrexate Injection Product
Table 79. Teva Recent Developments/Updates
Table 80. Accord Corporation Information
Table 81. Accord Description and Business Overview
Table 82. Accord Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Accord Methotrexate Injection Product
Table 84. Accord Recent Developments/Updates
Table 85. Fresenius Kabi Corporation Information
Table 86. Fresenius Kabi Description and Business Overview
Table 87. Fresenius Kabi Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Fresenius Kabi Methotrexate Injection Product
Table 89. Fresenius Kabi Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Mylan Methotrexate Injection Product
Table 94. Mylan Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Methotrexate Injection Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Get Well Pharmaceutical Corporation Information
Table 101. Get Well Pharmaceutical Description and Business Overview
Table 102. Get Well Pharmaceutical Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Get Well Pharmaceutical Methotrexate Injection Product
Table 104. Get Well Pharmaceutical Recent Developments/Updates
Table 105. Sichuan Huiyu Pharma Corporation Information
Table 106. Sichuan Huiyu Pharma Description and Business Overview
Table 107. Sichuan Huiyu Pharma Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sichuan Huiyu Pharma Methotrexate Injection Product
Table 109. Sichuan Huiyu Pharma Recent Developments/Updates
Table 110. Youcare Pharmaceutical Group Corporation Information
Table 111. Youcare Pharmaceutical Group Description and Business Overview
Table 112. Youcare Pharmaceutical Group Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Youcare Pharmaceutical Group Methotrexate Injection Product
Table 114. Youcare Pharmaceutical Group Recent Developments/Updates
Table 115. Qilu Pharmaceutical Corporation Information
Table 116. Qilu Pharmaceutical Description and Business Overview
Table 117. Qilu Pharmaceutical Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Qilu Pharmaceutical Methotrexate Injection Product
Table 119. Qilu Pharmaceutical Recent Developments/Updates
Table 120. Shanxi Pude Pharma Corporation Information
Table 121. Shanxi Pude Pharma Description and Business Overview
Table 122. Shanxi Pude Pharma Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Shanxi Pude Pharma Methotrexate Injection Product
Table 124. Shanxi Pude Pharma Recent Developments/Updates
Table 125. Hengrui Medicine Corporation Information
Table 126. Hengrui Medicine Description and Business Overview
Table 127. Hengrui Medicine Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Hengrui Medicine Methotrexate Injection Product
Table 129. Hengrui Medicine Recent Developments/Updates
Table 130. Guangdong Lingnan Pharma Corporation Information
Table 131. Guangdong Lingnan Pharma Description and Business Overview
Table 132. Guangdong Lingnan Pharma Methotrexate Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Guangdong Lingnan Pharma Methotrexate Injection Product
Table 134. Guangdong Lingnan Pharma Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Methotrexate Injection Distributors List
Table 138. Methotrexate Injection Customers List
Table 139. Methotrexate Injection Market Trends
Table 140. Methotrexate Injection Market Drivers
Table 141. Methotrexate Injection Market Challenges
Table 142. Methotrexate Injection Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Methotrexate Injection
Figure 2. Global Methotrexate Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Methotrexate Injection Market Share by Type in 2023 & 2030
Figure 4. Preservative-Free Product Picture
Figure 5. With Preservative Product Picture
Figure 6. Global Methotrexate Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Methotrexate Injection Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Specialty Clinic
Figure 10. Recovry Center
Figure 11. Global Methotrexate Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Methotrexate Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Methotrexate Injection Sales (2019-2030) & (K Units)
Figure 14. Global Methotrexate Injection Average Price (US$/Unit) & (2019-2030)
Figure 15. Methotrexate Injection Report Years Considered
Figure 16. Methotrexate Injection Sales Share by Manufacturers in 2023
Figure 17. Global Methotrexate Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Methotrexate Injection Players: Market Share by Revenue in 2023
Figure 19. Methotrexate Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Methotrexate Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Methotrexate Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Methotrexate Injection Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Methotrexate Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Methotrexate Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Methotrexate Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Methotrexate Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Methotrexate Injection Sales Market Share by Country (2019-2030)
Figure 45. Latin America Methotrexate Injection Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Methotrexate Injection Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Methotrexate Injection Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Methotrexate Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Methotrexate Injection by Type (2019-2030)
Figure 55. Global Revenue Market Share of Methotrexate Injection by Type (2019-2030)
Figure 56. Global Methotrexate Injection Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Methotrexate Injection by Application (2019-2030)
Figure 58. Global Revenue Market Share of Methotrexate Injection by Application (2019-2030)
Figure 59. Global Methotrexate Injection Price (US$/Unit) by Application (2019-2030)
Figure 60. Methotrexate Injection Value Chain
Figure 61. Methotrexate Injection Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
